TITLE

AOP-1 interacts with cardiac-specific protein kinase TNNI3K and down-regulates its kinase activity

AUTHOR(S)
Yan Feng; Dong-Qing Liu; Zhen Wang; Zhao Liu; Hui-Qing Cao; Lai-Yuan Wang; Na Shi; Xian-Min Meng
PUB. DATE
November 2007
SOURCE
Biochemistry (00062979);Nov2007, Vol. 72 Issue 11, p1199
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In the present study, a yeast two-hybrid screening system was used to identify the interaction partners of cardiac troponin I-interacting kinase (TNNI3K) that might serve as regulators or targets, and thus in turn to gain some insights on the roles of TNNI3K. After screening the adult heart cDNA library with a bait construct encoding the ANK motif of TNNI3K, antioxidant protein 1 (AOP-1) was isolated. The interaction between TNNI3K and AOP-1 was confirmed by the in vitro binding assay and coexpression experiments in vivo. The colocalization of TNNI3K and AOP-1 was clarified by confocal immunofluorescence. Moreover, coexpression of AOP-1 inhibited TNNI3K kinase activity in the in vitro kinase assay.
ACCESSION #
27605201

 

Related Articles

  • Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology. Neumann, Lars; Ritscher, Allegra; Müller, Gerhard; Hafenbradl, Doris // Journal of Computer-Aided Molecular Design;Aug2009, Vol. 23 Issue 8, p501 

    For the detection of the precise and unambiguous binding of fragments to a specific binding site on the target protein, we have developed a novel reporter displacement binding assay technology. The application of this technology for the fragment screening as well as the fragment evolution...

  • Computational Prediction and Experimental Verification of New MAP Kinase Docking Sites and Substrates Including Gli Transcription Factors. Whisenant, Thomas C.; Ho, David T.; Benz, Ryan W.; Rogers, Jeffrey S.; Kaake, Robyn M.; Gordon, Elizabeth A.; Lan Huang; Baldi, Pierre; Bardwell, Lee // PLoS Computational Biology;Aug2010, Vol. 6 Issue 8, p1 

    In order to fully understand protein kinase networks, new methods are needed to identify regulators and substrates of kinases, especially for weakly expressed proteins. Here we have developed a hybrid computational search algorithm that combines machine learning and expert knowledge to identify...

  • A new protein kinase cascade. Hardie, D. Grahame // Nature Reviews Molecular Cell Biology;Apr2014, Vol. 15 Issue 4, p223 

    The article presents information on a research report on protein kinase cascade.

  • DNA-dependent Protein Kinase Does Not Play a Role in Adaptive Survival Responses to Ionizing Radiation. Odegaard, Eric; Chin-Rang Yang; Boothman, David A.; Calabrese, Edward J. // Environmental Health Perspectives Supplements;Feb98 Supplement 1, Vol. 106, p301 

    Explores the role of the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) in adaptive survival responses by comparing severe combined immunodeficiency cells, which do not express DNA-PKcs protein, and parental mouse strain cells, which express normal levels of the DNA double-strand...

  • kinase:. Schlegel, Rolf H. J. // Encyclopedic Dictionary of Plant Breeding & Related Subjects;2003, p242 

    The article presents a definition of the term "kinase," which refers to an enzyme that catalyzes reactions involving the transfer of phosphates from a nucleoside triphosphate to another substrate.

  • Identification of a Kinase Profile that Predicts Chromosome Damage Induced by Small Molecule Kinase Inhibitors. Olaharski, Andrew J.; Gonzaludo, Nina; Bitter, Hans; Goldstein, David; Kirchner, Stephan; Uppal, Hirdesh; Kolaja, Kyle // PLoS Computational Biology;Jul2009, Vol. 5 Issue 7, p1 

    Kinases are heavily pursued pharmaceutical targets because of their mechanistic role in many diseases. Small molecule kinase inhibitors (SMKIs) are a compound class that includes marketed drugs and compounds in various stages of drug development. While effective, many SMKIs have been associated...

  • A Personalized BEST: Characterization of Latent Clinical Classes of Nonischemic Heart Failure That Predict Outcomes and Response to Bucindolol. Kao, David P.; Wagner, Brandie D.; Robertson, Alastair D.; Bristow, Michael R.; Lowes, Brian D. // PLoS ONE;Nov2012, Vol. 7 Issue 11, Special section p1 

    Background: Heart failure patients with reduced ejection fraction (HFREF) are heterogenous, and our ability to identify patients likely to respond to therapy is limited. We present a method of identifying disease subtypes using high-dimensional clinical phenotyping and latent class analysis that...

  • Medical Biochemistry.  // Clinical & Investigative Medicine;Dec98 Supplement, Vol. 21, pS58 

    The article presents various studies related to medical biochemistry. These studies include the identification of rare cells with chromosomal abnormalities in peripheral blood using fluorescence in situ hybridization, antioxidant defense system in diabetic rat liver and pancreas and...

  • Phosphorylation regulates the stability of the regulatory CK2β subunit. Cunjie Zhang; Vilk, Greg; Canton, David A.; Litchfield, David W. // Oncogene;5/23/2002, Vol. 21 Issue 23, p3754 

    Demonstrates that protein kinase CK2β is degraded by a proteasome-dependent pathway and that it is ubiquitinated. Role of phosphorylation and a putative destruction box in regulating its stability in cells; Description of CK2; Mechanisms that control the turnover of CK2β.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics